TNF and myelodysplastic syndrome: 5‐Aminosalicylic acid and tumor necrosis factor‐α (TNF‐α) inhibitors may offer some benefit for intestinal Behçet‐like lesions, though the therapeutic effect is generally inferior to MDS‐directed therapies.